[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100592629":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":11,"centralContacts":23,"locations":29,"responsibleParty":45,"collaborators":11,"id":47,"slug":11,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":11,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":11,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":66,"overallStatus":31,"whyStopped":11,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Shanghai Eye Disease Prevention and Treatment Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Nearwork with the Virtual Far-sight Reading Device","EXPERIMENTAL",null,[13],"Device: Virtual Far-sight Reading Device",{"label":15,"type":16,"description":11,"interventionNames":11},"Nearwork without the Virtual Far-sight Reading Device","NO_INTERVENTION",[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":11},"DEVICE","Virtual Far-sight Reading Device","The Virtual Far-sight Reading Device utilizes a birdbath optical configuration and freeform surface technology to extend the working distance from 30 cm to over 6 meters, thereby simulating distance viewing conditions and maintaining ciliary muscle relaxation. Study participants were required to engage in reading and writing tasks using the device for a cumulative daily duration of at least 1 hour.",[9],[24],{"name":25,"role":26,"phone":27,"phoneExt":11,"email":28},"Wei Xu, Prof","CONTACT","+86 18521513008","vvxuwei@163.com",[30],{"facility":5,"status":31,"city":32,"state":11,"zip":11,"country":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"RECRUITING","Shanghai","China",{"type":35,"coordinates":36},"Point",[37,38],121.45806,31.22222,{"lat":38,"lon":37},[41],{"name":42,"role":26,"phone":43,"phoneExt":11,"email":44},"Tianyu Cheng, Dr","+86 18817552005","s70444@126.com",{"type":46,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100592629",false,"NCT06995911","Virtual Far-sight Reading Device for Myopia Intervention Among Pre-myopic Children","A Randomized Controlled Clinical Trial on the Efficacy and Safety of the Virtual Far-sight Reading Device for Myopia Intervention in Pre-myopic Children","Inclusion Criteria:\n\n* Age: 6-12 years (inclusive), gender unrestricted.\n\n  * Worse eye cycloplegic spherical equivalent refraction (SER): -0.5 D \\\u003C SER ≤ +0.75 D; Cylinder ≤ -1.5 D in both eyes; Interocular anisometropia ≤ 1.5 D ③ Visual acuity: Best-corrected visual acuity (BCVA) ≤ 0.1 logMAR in both eyes. ④ Family history: At least one parent with myopia.\n\n    * Intraocular pressure (IOP): 10-21 mmHg in both eyes; Interocular IOP difference ≤ 5 mmHg\n\n      ⑥ Compliance: Commitment to daily home use of the Far-Image Light Field Desk per protocol, immediate notification to investigators if unable to comply, and completion of scheduled follow-ups.\n\n      ⑦ Informed consent: Signed assent form (minor) and written informed consent from legal guardian.\n\nExclusion Criteria:\n\n* Ocular comorbidities affecting vision\u002Frefractive development: Marfan syndrome; Lens pathologies (e.g., cataracts); Glaucoma; retinal detachment; retinopathy of prematurity\n\n  * Systemic diseases: Immune\u002FCNS disorders; Down syndrome; Severe cardiopulmonary\u002Fhepatic\u002Frenal dysfunction; Uncontrolled asthma\n\n    * Ocular abnormalities: Manifest strabismus; Binocular vision dysfunction; Pathological ocular changes or active ocular inflammation ④ Recent myopia interventions (within 3 months prior to screening): Orthokeratology; multifocal contact lenses; Functional spectacles, red-light therapy\n\n      ⑤ Medications affecting efficacy evaluation (within 3 months): Anticholinergics (e.g., atropine, pirenzepine); Cholinergics (e.g., pilocarpine)\n\n      ⑥ Participation in other clinical trials within 3 months.\n\n      ⑦ Contraindications\u002Fallergies to cycloplegics or study-related medications.\n\n      ⑧ Chronic psychiatric disorders or cognitive impairment.\n\n      ⑨ Other conditions deemed unsuitable by investigators.","ALL","6 Years","12 Years",{"count":57,"type":58},80,"ESTIMATED","INTERVENTIONAL",[61],"NA","This clinical trial wants to find out if the Virtual Far-sight Reading Device can help prevent or slow down myopia progression in children and teenagers with pre-myopia. We also want to know what makes this treatment work better for some participants and check for any eye or body-related side effects over time.\n\nMain questions:\n\nCan using the Virtual Far-sight Reading Device reduce the risk of myopia? Is the device safe to use every day for up to 6 months?\n\nWhat we'll do:\n\nResearchers will compare two groups of children:\n\nGroup A: Uses the device for reading\u002Fwriting (at least 1 hour daily) Group B: Does regular reading\u002Fwriting without the device After 90 days, the groups will switch to see if the results stay the same.\n\nParticipants will:\n\n* Have free eye checkups 3 times over 6 months\n* Use the device during homework time (if in the desk group)\n* Report any eye discomfort or problems",[64,65],"Myopia","Pre-myopia",[64,65],"2026-05-21",{"date":69,"type":70},"2026-05-26","ACTUAL",{"date":72,"type":70},"2025-06-01",{"date":74,"type":58},"2026-05-31",{"name":5,"class":6},1]